BORTEZOMIB TRADE DATA ANALYSIS
Analyze Bortezomib export import data and locate key markets, reliable suppliers, and active buyers by utilizing Eximpedia's data-centric platform.Whether you're a supplier looking for high-demand markets or a buyer sourcing apples from reliable exporters, Eximpedia’s data-driven approach for making informed trade decisions.
BORTEZOMIB – Overview
Eximpedia analyses Bortezomib export import records, including data from 396 buyers and 100 suppliers. We provide an intelligence report of Apple that covers trade statistics, shipment values, quantities, exporters & importers, trade destinations, and HS codes.
Bortezomib Buyers, Suppliers & Shipments
Products Bortezomib import markets
Gain insights into Product Bortezomib with data on monthly import values, major importing countries, key ports, leading competitors, and active suppliers.
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 30049068813 | 537.73 | 38 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049068818 | 57.28 | 7 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049049 | 15.35 | 30 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049068815 | 5.92 | 14 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004900000 | 4.92 | 24 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| CANADA | 209.62 | 19 | 0.00 |
| INDIA | 153.86 | 94 | 0.00 |
| IRELAND | 90.06 | 7 | 0.00 |
| CYPRUS | 82.59 | 2 | 0.00 |
| FINLAND | 57.28 | 7 | 0.00 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| EZEIZA | 595.42 | 60 | 0.00 |
| BOMBAY AIR CARGO | 0.45 | 46 | 0.00 |
| HYDERABAD AIR CARGO | 0.17 | 43 | 0.00 |
| ISTANBUL AIRPORT CUSTOMS DIRECTORATE | 2.69 | 24 | 0.00 |
| SANTAMARIA | 0.06 | 16 | 0.00 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| GADOR SA | 209.28 | 591 |
| MSD ARGENTINA SRL | 147.34 | 1207 |
| MINISTRY OF HEALTH | 150.06 | 1225 |
| VIFRANCO PHARMA COMPANY LIMITED | 10.81 | 100 |
| BIOSIDUS SOCIEDAD ANONIMA | 82.59 | 205 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|
Discover the Hidden Opportunities in HS Code Bortezomib—access key decision-makers and detailed reports to save time and succeed.
Bortezomib Import Market
Explore Product Bortezomib with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 3004900000 | 1. MEDICINAL PRODUCT FOR THERAPEUTIC OR PROPHYLACTIC USE, PACKAGED FOR RETAIL SALE, FOR HUMANS: - BENTERO - (ACTIVE SUBSTANCE - 1 VIAL CONTAINS 25 MG OF BENDAMUSTINE HYDROCHLORIDE) - LYOPHILISATE FOR SOLUTION FOR INJECTION OF 25 MG; 1 VIAL OF LYOPHILISATE IN A CARDBOARD BOX - 120 PACKS. EXPIRY DATE UNTIL 06.2026, SERIES BET123601B - 40 PACKS; SERIES BET123602A - 40 PACKS; SERIES BET123603A - 40 PACKS - BENTERO - (ACTIVE SUBSTANCE - 1 VIAL CONTAINS 100 MG OF BENDAMUSTINE HYDROCHLORIDE) - LYOPHILISATE FOR SOLUTION FOR INJECTION 100 MG EACH; 1 VIAL WITH LYOPHILISATE IN A CARDBOARD BOX - 160 PACKS. EXPIRY DATE UNTIL 04.2026, SERIES BET223604C - 40 PACKS. EXPIRY DATE UNTIL 06.2026, SERIES BET223605A - 40 PACKS. EXPIRY DATE UNTIL 07.2026, SERIES BET223606A - 40 PACKS; SERIES BET223607A - 40 PACKS - BORTERO - (ACTIVE SUBSTANCE - 1 BOTTLE CONTAINS BORTEZOMIB 3.5 MG) - LYOPHILISATE FOR SOLUTION FOR INJECTION, 3.5 MG EACH 1 VIAL WITH LYOPHILISATE IN A CARDBOARD BOX - 40 PACKS. THE TERM AT |  |
|
INDIA | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCT, ACCORDING TO THE AGREEMENT CONCLUDED BETWEEN SE ""MEDICAL PROCUREMENT OF UKRAINE"" AND LLC ""DIATOM"": MEDICINAL PRODUCT FOR THERAPEUTIC OR PROPHYLACTIC USE, PACKAGED FOR RETAIL SALE, FOR HUMANS:- BENTERO - (ACTIVE SUBSTANCE - 1 VIAL CONTAINS 25 MG OF BENDAMUSTINE HYDROCHLORIDE) - 25 MG LYOPHILISATE FOR SOLUTION FOR INJECTION; 1 VIAL WITH LYOPHILISATE IN A CARDBOARD BOX - 8192 PACKS. EXPIRY DATE UNTIL 06.2026, SERIES BET123601B - 2592 PACKS; SERIES BET123602A - 2826 PACKS; SERIES BET123603A - 2774 PACKS - BENTERO - (ACTIVE SUBSTANCE - 1 BOTTLE CONTAINS 100 MG OF BENDAMUSTINE HYDROCHLORIDE) - LYOPHILISATE FOR SOLUTION FOR INJECTION 100 MG EACH; 1 VIAL WITH LYOPHILISATE IN A CARDBOARD BOX - 6918 PACKS. EXPIRY DATE UNTIL 04.2026, SERIES BET223604C - 754 PACKS. EXPIRY DATE UNTIL 06.2026, SERIES BET223605A - 2007 PACK. EXPIRY DATE UNTIL 07.2026, SERIES BET223606A - 2072 PACKS; SERIES BET223607A - 2085 PACKS - BORTERO - (ACTIVE SUBSTANCE - 1 BOTTLE CONTAINS BORTEZOMIB 3," | |
|
INDIA | UKRAINE | 0 |
| 30049089000 | 1 PACKAGE PHARMACEUTICAL PRODUCTS (100 VIAL) VORTESTAR 3.5 (BORTEZOMIB) | |
|
INDIA | PHILIPPINES | 1 |
| 848041 | BORTEZOMIB FOR INJECTION 3.5MG | |
|
CN, CHINA | USA | 261 |
| 848041 | BORTEZOMIB FOR INJECTION HTS | |
|
CN, CHINA | USA | 94 |
| 30049099 | BORTEZOMIB INJ 2.5 MG/1ML (QTY: 144 NOS, PRICE:EUR. 0.7 EACH) | |
|
ITALY | INDIA | 144 |
| 30049099 | BORTEZOMIB INJ 2.5 MG/1ML (QTY: 144 NOS, PRICE:EUR. 0.7 EACH) | |
|
ITALY | INDIA | 144 |
| 30049049 | HARMLESS PHARMACEUTICAL MEDICINE .MIBOR 2MG INJ(BORTEZOMIB 2MG INJ) (SB NO.5087048 DT.02.11.2023) (RBD SHIPMENT) | |
|
INDIA | INDIA | 30 |
| 30049044 | HARMLESS PHARMACEUTICAL MEDICINE .VELZOC ADE 3.5MG INJ. (BORTEZOMIB 3.5MG INJECTI ON) (SB NO.5087048 DT.02.11.2023) (R | |
|
INDIA | INDIA | 30 |
| 848041 | BORTEZOMIB FOR INJECTION HTS | |
|
CN, CHINA | USA | 94 |
| 848041 | BORTEZOMIB FOR INJECTION HTS | |
|
CN, CHINA | USA | 462 |
| 848041 | BORTEZOMIB FOR INJECTION HTS | |
|
CN, CHINA | USA | 556 |
| 848041 | BORTEZOMIB FOR INJECTION HTS | |
|
CN, CHINA | USA | 553 |
| 848041 | BORTEZOMIB FOR INJECTION HTS | |
|
CN, CHINA | USA | 556 |
| 848041 | BORTEZOMIB FOR INJECTION HTS | |
|
CN, CHINA | USA | 462 |
| 848041 | BORTEZOMIB FOR INJECTION HTS | |
|
CN, CHINA | USA | 553 |
| 3004900000 | BORTEZOMIB 1MG (1BTLX14) CA057OLMUL P3 | |
|
BELGIUM | TURKEY | 300 |
| 3004900000 | BORTEZOMIB LINJ 3.5MG (1VL) CA057 OLMUL | |
|
BELGIUM | TURKEY | 100 |
| 3004900000 | BORTEZOMIB 3,5 MG (1V.L.)C.A.057 BE MUL | |
|
SWITZERLAND | TURKEY | 100 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Products Bortezomib export markets
Discover Products Bortezomib with data on monthly export values, major exporting countries, key ports, leading competitors, and active buyers.
TOP EXPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 30049049 | 25.26 | 578 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049089 | 15.70 | 15 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 30049068818 | 15.62 | 43 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 29349990 | 7.49 | 13 | 0.00 |
| NUCLEIC ACIDS AND THEIR SALTS; WHETHER OR NOT CHEMICALLY DEFINED; OTHER HETEROCYCLIC COMPOUNDS | |||
| 30049068816 | 6.63 | 51 | 0.00 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP EXPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| ALGERIA | 15.70 | 15 | 0.00 |
| FREE ZONE AMERICA | 12.46 | 10 | 0.00 |
| BRAZIL | 8.61 | 96 | 0.00 |
| UNITED STATES | 8.47 | 86 | 0.00 |
| GERMANY | 7.43 | 57 | 0.00 |
TOP EXPORT PORTS
| PORTS | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| BOMBAY AIR CARGO | 2.95 | 489 | 0.00 |
| HYDERABAD AIR CARGO | 23.78 | 272 | 0.00 |
| DELHI AIR CARGO | 3.60 | 232 | 0.00 |
| EZEIZA | 14.16 | 127 | 0.00 |
| VISAKHAPATNAM SPECIAL ECONOMIC ZONE (SEZ) | 9.83 | 103 | 0.00 |
TOP EXPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| MONTE VERDE S A | 12.46 | 269 |
| PT CKD OTTO PHARMACEUTICALS | 15.70 | 2 |
| LAURUS LABS LIMITED | 7.49 | 1857 |
| DR REDDYS LABORATORIES LIMITED FORMULATION UNIT | 5.76 | 735 |
| MSN LABORATORIES PRIVATE LIMITED | 5.46 | 6246 |
TOP EXPORT BUYERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| PFIZER ASIA MANUFACTURING PRIVATE LIMITED | 2.01 | 49 |
| GROUPE INDUSTRIEL SAIDAL SPA | 15.70 | 5 |
| THYMOORGAN PHARMAZIE GMBH | 4.96 | 16 |
| EUGIA US LLC | 2.04 | 1101 |
| OOO JODAS EXPOIM | 2.61 | 430 |
Access the complete database of 396 buyers and 100 suppliers with a one-time subscription plan.
Bortezomib Export Market
Analyze HSN Code Bortezomib with product description, export values, quantities, importer name, country of origin and key import destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 30049068812 | BORTEZOMIB. ALTRETAMINA; BORTEZOMIB; DISOPROXILFUMARATO DE TENOFOVIR; ENFUVIRTIDA; MESILATO DE IMATINIB; PEMETREXED; SULFATO DE ATAZANAVIR; TEMOZOLOMIDA; URACIL Y TEGAFUR. ALTRETAMINA; BORTEZOMIB; DISOPROXILFUMARATO DE TENOFOVIR; ENFUVIRTIDA; MESILATO DE | |
|
ARGENTINA | VENEZUELA, BOLIVARIAN REPUBLIC OF | 200 |
| 30049068816 | PEMETREXED. ALTRETAMINA; BORTEZOMIB; DISOPROXILFUMARATO DE TENOFOVIR; ENFUVIRTIDA; MESILATO DE IMATINIB; PEMETREXED; SULFATO DE ATAZANAVIR; TEMOZOLOMIDA; URACIL Y TEGAFUR. ALTRETAMINA; BORTEZOMIB; DISOPROXILFUMARATO DE TENOFOVIR; ENFUVIRTIDA; MESILATO DE | |
|
ARGENTINA | PARAGUAY | 2 |
| 30049068816 | PEMETREXED. ALTRETAMINA; BORTEZOMIB; DISOPROXILFUMARATO DE TENOFOVIR; ENFUVIRTIDA; MESILATO DE IMATINIB; PEMETREXED; SULFATO DE ATAZANAVIR; TEMOZOLOMIDA; URACIL Y TEGAFUR. ALTRETAMINA; BORTEZOMIB; DISOPROXILFUMARATO DE TENOFOVIR; ENFUVIRTIDA; MESILATO DE | |
|
ARGENTINA | URUGUAY | 150 |
| 30049068816 | PEMETREXED. ALTRETAMINA; BORTEZOMIB; DISOPROXILFUMARATO DE TENOFOVIR; ENFUVIRTIDA; MESILATO DE IMATINIB; PEMETREXED; SULFATO DE ATAZANAVIR; TEMOZOLOMIDA; URACIL Y TEGAFUR. ALTRETAMINA; BORTEZOMIB; DISOPROXILFUMARATO DE TENOFOVIR; ENFUVIRTIDA; MESILATO DE | |
|
ARGENTINA | VENEZUELA, BOLIVARIAN REPUBLIC OF | 40 |
| 30049068812 | BORTEZOMIB. ALTRETAMINA; BORTEZOMIB; DISOPROXILFUMARATO DE TENOFOVIR; ENFUVIRTIDA; MESILATO DE IMATINIB; PEMETREXED; SULFATO DE ATAZANAVIR; TEMOZOLOMIDA; URACIL Y TEGAFUR. ALTRETAMINA; BORTEZOMIB; DISOPROXILFUMARATO DE TENOFOVIR; ENFUVIRTIDA; MESILATO DE | |
|
ARGENTINA | VENEZUELA, BOLIVARIAN REPUBLIC OF | 200 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 2985 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 2940 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 1369 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 3923 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 885 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 5086 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 3005 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 8381 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 256 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 6690 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 3967 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 2974 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 15291 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 1247 |
| 30049089 | BORTEZOMIB SAIDAL 3.5 MG | |
|
INDONESIA | ALGERIA | 1040 |
Why should you choose Eximpedia?
Deep-Analysis Report
Get reports on market trends, price, volume, HS Code supply, product details, country of origin, number of buyers & suppliers, and total shipments with Eximpedia's deep analysis reports.
Access Database Across 130+ Countries
Gain statistical and analytical reports, competitors' shipment records, and country-specific data from over 130 countries.
20 types of unique dashboards
Eximpedia offers 20 types of unique dashboards, tailored to meet diverse business needs. From trade insights to buyer analysis, each dashboard delivers actionable data at your fingertips.
Effortless Global Buyer Discovery
Explore international markets with ease! Access over 5 billion records to identify buyers in 130+ countries with just a click.
Supplier Stability Monitor
Leverage historical shipment data and real-time alerts for a complete view of supplier reliability and performance.
Competitor Pricing Strategy Intelligence
Utilise our data-driven platform to uncover competitors’ pricing strategies and track market pricing trends.